HomeCompareVBIO vs KO

VBIO vs KO: Dividend Comparison 2026

VBIO yields 512.82% · KO yields 3.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VBIO wins by $74719.35M in total portfolio value
10 years
VBIO
VBIO
● Live price
512.82%
Share price
$0.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$74719.37M
Annual income
$54,003,807,702.14
Full VBIO calculator →
KO
The Coca-Cola Company
● Live price
3.11%
Share price
$63.10
Annual div
$1.96
5Y div CAGR
4.2%
Payout ratio
71%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.0K
Annual income
$610.29
Full KO calculator →

Portfolio growth — VBIO vs KO

📍 VBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVBIOKO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VBIO + KO cover 4 of 12 monthsgood coverage

Jan
Feb
Mar
KO
Apr
May
Jun
KO
Jul
Aug
Sep
KO
Oct
Nov
KO
Dec
VBIO pays
KO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VBIO
Annual income on $10K today (after 15% tax)
$43,589.74/yr
After 10yr DRIP, annual income (after tax)
$45,903,236,546.82/yr
KO
Annual income on $10K today (after 15% tax)
$264.03/yr
After 10yr DRIP, annual income (after tax)
$518.75/yr
At 15% tax rate, VBIO beats the other by $45,903,236,028.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VBIO + KO for your $10,000?

VBIO: 50%KO: 50%
100% KO50/50100% VBIO
Portfolio after 10yr
$37359.70M
Annual income
$27,001,904,156.21/yr
Blended yield
72.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KO right now

VBIO
No analyst data
KO
Analyst Ratings
29
Buy
16
Hold
3
Sell
Consensus: Buy
Price Target
$84.88
+34.5% upside vs current
Range: $81.00 — $88.00
Altman Z
5.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VBIO buys
0
KO buys
0
No recent congressional trades found for VBIO or KO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVBIOKO
Forward yield512.82%3.11%
Annual dividend / share$2.00$1.96
Payout ratio50%71%
1-year div growth0%5.4%
5-year div CAGR0%4.2%
Portfolio after 10y$74719.37M$22.0K
Annual income after 10y$54,003,807,702.14$610.29
Total dividends collected$72929.43M$4.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: VBIO vs KO ($10,000, DRIP)

YearVBIO PortfolioVBIO Income/yrKO PortfolioKO Income/yrGap
1← crossover$61,982$51,282.05$10,834$323.66+$51.1KVBIO
2$363,383$297,062.31$11,734$347.64+$351.6KVBIO
3$2,016,476$1,627,655.79$12,706$373.31+$2.00MVBIO
4$10,598,885$8,441,255.59$13,754$400.76+$10.59MVBIO
5$52,806,644$41,465,837.52$14,886$430.12+$52.79MVBIO
6$249,582,121$193,079,012.24$16,107$461.52+$249.57MVBIO
7$1,119,909,823$852,856,952.70$17,423$495.09+$1119.89MVBIO
8$4,774,834,551$3,576,531,040.71$18,843$530.98+$4774.82MVBIO
9$19,360,340,566$14,251,267,596.86$20,373$569.32+$19360.32MVBIO
10$74,719,372,108$54,003,807,702.14$22,022$610.29+$74719.35MVBIO

VBIO vs KO: Complete Analysis 2026

VBIOStock

Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.

Full VBIO Calculator →

KOConsumer Staples

Coca-Cola is a Dividend King with 62+ consecutive years of dividend increases. Operating in 200+ countries with brands including Coke, Sprite, Fanta, and Dasani. Warren Buffett's Berkshire Hathaway holds ~$24B in KO stock — and his yield on cost exceeds 50% from his 1980s purchases, illustrating the power of long-term dividend compounding.

Full KO Calculator →
📬

Get this VBIO vs KO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VBIO vs SCHDVBIO vs JEPIVBIO vs OVBIO vs MAINVBIO vs PEPVBIO vs PGVBIO vs JNJVBIO vs MCD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.